Status:
COMPLETED
CKD-aP Among Adults on Dialysis in Switzerland
Lead Sponsor:
University of Applied Sciences of Western Switzerland
Collaborating Sponsors:
University of Lausanne Hospitals
Hôpital Fribourgeois
Conditions:
Chronic Kidney Diseases
Dialysis
Eligibility:
All Genders
18+ years
Brief Summary
Chronic Kidney Disease Associated Pruritus (CKD-aP) represents a localized or a generalized skin itch, which is a common symptom occurring in end-stage renal disease and dialysis. The prevalence of CK...
Eligibility Criteria
Inclusion
- Adult ≥ 18 years old
- Diagnosed with end-stage renal disease and receiving hemodialysis for at least 6 months
- Able to communicate in French or availability of a French-speaking close relative for translation
- Signed informed consent
- Additional inclusion criteria for the case-control study outcomes phase 2:
- Reporting moderate to severe CKD-aP for the participant considered as a case
- Reporting no or mild CKD-aP for the participant considered as a control Cases and controls will be matched by age-group, sex, and dialysis modality (hemodialysis or peritoneal dialysis).
Exclusion
- Presence of cognitive impairment or cognitive disorder
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 9 2023
Estimated Enrollment :
401 Patients enrolled
Trial Details
Trial ID
NCT05415969
Start Date
September 1 2022
End Date
October 9 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Lausanne Hospitals
Lausanne, Canton of Vaud, Switzerland, 1011